I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Neoadjuvant nivolumab + T-VEC combination therapy for resec..:
Maartje W. Rohaan
;
Emma H. A. Stahlie
;
Viola Franke
...
https://doi.org/10.1186/s12885-022-09896-4. , 2022
Link:
https://doi.org/10.1186/s12885-022-09896-4
RT Journal T1
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:7d1e6b458ad644d8942e1babbaf34492&Exemplar=1&LAN=DE A1 Maartje W. Rohaan A1 Emma H. A. Stahlie A1 Viola Franke A1 Lisanne P. Zijlker A1 Sofie Wilgenhof A1 Vincent van der Noort A1 Alexander C. J. van Akkooi A1 John B. A. G. Haanen PB BMC YR 2022 K1 Melanoma K1 Early metastatic K1 Neoadjuvant K1 Talimogene laherparepvec K1 Nivolumab K1 Immune checkpoint inhibitor K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s12885-022-09896-4 LK http://dx.doi.org/https://doi.org/10.1186/s12885-022-09896-4 DO https://doi.org/10.1186/s12885-022-09896-4 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)